Brief introduction of Harbin medicine

Harbin Pharmaceutical Group Co., Ltd. is a state-controlled Sino-foreign joint venture. It owns well-known domestic pharmaceutical manufacturers such as Harbin Pharmaceutical General Factory, Harbin Pharmaceutical Sanjing, Harbin Pharmaceutical No.6 Factory, Harbin Pharmaceutical Traditional Chinese Medicine Company, Harbin Pharmaceutical Biovaccine and other commercial circulation enterprises. It owns two listed companies, namely Harbin Pharmaceutical Co., Ltd. and Harbin Pharmaceutical Co., Ltd., of which Harbin Pharmaceutical Group holds 45.06% and Harbin Pharmaceutical Co., Ltd. holds 74.82% of Sanjing Pharmaceutical. Harbin Pharmaceutical Group integrates pharmaceutical manufacturing, trade and scientific research, and its main business covers seven industrial fields: antibiotics, chemical pharmaceutical preparations, over-the-counter drugs and health care products, modern Chinese medicine, bioengineering drugs, animal vaccines and pharmaceutical circulation. * * * Production of more than 20 dosage forms, 1000 varieties. The annual output of APIs and intermediates is 65.438+0.5 million tons, 2 billion powder injections of western medicine, 65.438+0 billion powder injections of traditional Chinese medicine, 65.438+0.8 billion water injections, 65.438+0.65438+0 billion tablets, 65.438+0.4 billion capsules and 2.2 billion oral liquids.